Biomarkers & Precision Medicine US 2025

In-session Presentation: Subcellular multi-omic imaging of the entire protein-coding transcriptome: Technology to discover biomarkers that really work!

Monday, October 27 | 11:25 – 11:50 AM | Conference Room 1

Spatial Biology for Precision Medicine Track

The newly released CosMx® Whole Transcriptome (WTX) assay enables subcellular imaging of ~19,000 RNA transcripts directly from standard FFPE tissue, with same-slide integration of high-plex protein imaging (up to 76-plex). This unbiased multiomic approach generates rich datasets for data-driven machine learning, uncovering unexpected pathway activities and resolving the “blind-spot” problem inherent in targeted panels. Complementing WTX, the GeoMx® DSP platform now supports high-throughput spatial proteomics with the 1,200-plex Discovery Proteome Atlas, together providing a comprehensive solution for spatial biomarker discovery and development.

Presenter: 

              Joe Beechem, Ph.D.

                   CSO & SVP of R&D

                   Bruker Spatial Biology

Panel Discussion: Moving From Discovery Phases to Clinical Trials in Spatial Biology

Tuesday, October 28 | 2:30 – 2:55 PM | Conference Room 4

An interactive discussion highlighting the role of spatial technologies in discovery, practical strategies for clinical adoption, and methods shaping their path to clinical trials.

Conference Overview: Biomarkers & Precision Medicine US 2025

Biomarkers & Precision Medicine US 2025 brings together global leaders from pharma, biotech, and academia to showcase the latest innovations in precision-guided therapies. Celebrating its 9th year, the conference features dedicated programmes in Biomarkers, Spatial Biology for Precision Medicine, and Digital Pathology & AI. Covering areas from biomarker discovery to clinical trials and patient stratification, the agenda highlights breakthroughs in spatial multi-omic analysis, digital pathology, and regulatory strategy. Interactive discussions and expert-led sessions foster collaboration and equip attendees with tools to advance diagnostics and therapeutic development.